Literature DB >> 17321637

Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways.

Ashok Kumar1, Rohit A Sinha, Meenakshi Tiwari, Rajesh Singh, Takehiko Koji, Namratta Manhas, Leena Rastogi, Lily Pal, Ashutosh Shrivastava, Ravi P Sahu, Madan M Godbole.   

Abstract

BACKGROUND/AIMS: The molecular basis of hepatic dysfunction in thyrotoxicosis is not fully understood. Here, we investigated the effect of altered thyroidal status on death receptor pathways including p75 neurotrophin receptor (p75NTR), a member of tumor necrosis factor (TNF) receptor superfamily, in rat liver.
METHODS: Hyperthyroidism was induced in Sprague-Dawley rats by daily injections of triiodothyronine in a dose of 12.5 microg/100 g body weight for 10 days.
RESULTS: Terminal deoxynucleotide-transferase-mediated dUTP nick end labeling assay and caspase-3 activation data confirmed apoptosis in hyperthyroid rat liver. We observed the elevated levels of death ligands, TNF-alpha, Fas ligand and their cognate receptors, TNF-receptor-1 and Fas, and 8-fold increase in caspase-8 activation in hyperthyroid rat liver (p<0.001). We demonstrated for the first time that hyperthyroidism elevates p75NTR levels and its ligands, pro-nerve growth factor and pro-brain-derived neurotrophic factor, in rat liver. Further we showed that most of the apoptotic cells in hyperthyroid liver express p75NTR. We also demonstrated that triiodothyronine administration to rats causes NF-kappaB activation, but persistent exposure (10 days) to triiodothyronine deactivates NF-kappaB leading to sustained c-Jun N-terminal kinase (JNK) activation.
CONCLUSIONS: This study showed that hyperthyroidism-induced apoptosis in rat liver involves the activation of death receptor-mediated pathways, including p75NTR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321637     DOI: 10.1016/j.jhep.2006.12.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy.

Authors:  Rohit Anthony Sinha; Seo-Hee You; Jin Zhou; Mobin M Siddique; Boon-Huat Bay; Xuguang Zhu; Martin L Privalsky; Sheue-Yann Cheng; Robert D Stevens; Scott A Summers; Christopher B Newgard; Mitchell A Lazar; Paul M Yen
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

2.  Factors predicting abnormal liver function tests induced by Graves' disease alone: a retrospective cohort study.

Authors:  Ruiguo Zhang; Xun Tian; Lan Qin; Xiaoer Wei; Junqi Wang; Jie Shen
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

3.  Independent Association of Serum Fibroblast Growth Factor 21 Levels With Impaired Liver Enzymes in Hyperthyroid Patients.

Authors:  Fangsen Xiao; Jinyang Zeng; Peiying Huang; Bing Yan; Xin Zeng; Changqin Liu; Xiulin Shi; Liying Wang; Haiqu Song; Mingzhu Lin; Shuyu Yang; Zhibin Li; Xuejun Li; Chao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-14       Impact factor: 5.555

4.  The role of fish oil in attenuating cardiac oxidative stress, inflammation and fibrosis in rat model of thyrotoxicosis.

Authors:  F Mayyas; A Alsaheb; K H Alzoubi
Journal:  Heliyon       Date:  2019-12-04

5.  Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy.

Authors:  Raquel López-Fontal; Miriam Zeini; Paqui G Través; Mariana Gómez-Ferrería; Ana Aranda; Guillermo T Sáez; Concha Cerdá; Paloma Martín-Sanz; Sonsoles Hortelano; Lisardo Boscá
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.